ArticlemAbs
A stable IgG-like bispecific antibody targeting the epidermal growth factor receptor and the type I insulin-like growth factor receptor demonstrates superior anti-tumor activity.
Jianying Dong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
43 papers cite it
cites it